comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 15:15:18 - browse：34426

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： He's a Nobel laureate. Critics say he was misleading on Covid

focus

explore

WSS

Antivenom research: Lessons from HIV applied in search for universal antidote

ASCO Daily Recap: CAR

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Finland to offer bird flu vaccine to select groups of people, a possible global first

How CO2 helps viruses stay alive longer in the air

Alabama frozen embryo ruling has major implications for IVF clinics

Wikipedia

comprehensive

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Data don't support strong claims for Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stopping antidepressants leads to symptoms for 1 in 6 patients

Apple is now the first public company to be valued at $3 trillion

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Senators tussle over abortion against the backdrop of a presidential campaign

After affirmative action ruling, medical educators look to 'holistic review'

'Little Tech' descents on D.C., wanting a say in how AI is regulated

focus

Anthony Fauci pushes back on GOP claims during Covid hearing

New documents shed light on MD Anderson Cancer Institute feud

Medicare inequities exacerbate Puerto Rico’s health disparities

A new nitrogen execution bill also undermines medical licensing

Senators tussle over abortion against the backdrop of a presidential campaign

NIH study of ME/CFS points to clear biological hallmarks

focus

explore

explore

leisure time